What does transfer mean in SSA

Slides:



Advertisements
Similar presentations
St Marys Hospital Ingrid V. Bassett, MD, MPH Massachusetts General Hospital Harvard Medical School May 25, 2010 Who Starts ART in Durban, South Africa?
Advertisements

TB/HIV Integration What it entails Frank Lule, Eyerusalem Negussie, Reuben Granich, Haileyesus Getahun.
Draft Generic Protocol: Measuring Impact and Effectiveness of National Programs for Prevention of Mother-To-Child HIV Transmission at Population-Level.
Risk factors and true outcomes of children lost to follow-up from antiretroviral therapy in Lilongwe, Malawi C. Ardura Gracia, H. Tweya, C Feldacker, S.
Antiretroviral therapy eligibility at enrollment and time to treatment initiation in Ethiopia Chloe A. Teasdale 1, Chunhui Wang 1, Sileshi Lulseged 1,
Urgent need to strengthen active tracing of lost to follow up cases: a prospective cohort study of newly diagnosed HIV clients in rural districts, Zambia.
Prevalence of and Progression to Abnormal Non-Invasive Markers of Liver Disease (APRI and FIB-4) among US HIV-infected Youth Kapogiannis B, Leister E,
The Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Linda-Gail Bekker The implementation of this project was made possible.
Community adherence support sustains improved three year outcomes for children on ART A. Grimwood 1, G. Fatti 1, E. Mothibi 1, M. Malahlela.
Primary Healthcare Facilities Deliver More Effective Antiretroviral Therapy: An Evaluation in Four Provinces in South Africa Geoffrey Fatti, Ashraf Grimwood.
Costs and Outcomes of AIDS Treatment Delivery Models Sydney Rosen ab, Lawrence Long b, Ian Sanne bc a Center for International Health and Development,
Stable Outcomes and Costs in South African Patients’ Second Year on Antiretroviral Treatment Lawrence Long, Health Economics Research Office, Wits Health.
© 2010 Baylor College of Medicine Post-18 month confirmatory HIV testing in HIV DNA PCR positive children: retrospective descriptive analysis from an operational.
Preliminary findings of a routine PMTCT Option B+ programme in a rural district in Malawi Rebecca M. Coulborn 1, Laura Triviño Duran 1, Carol Metcalf 2,
40 countries New sites added to regions since we began:  CCASAnet – Mexico  West Africa – Nigeria  Southern Africa – Zambia  Asia – Vietnam.
The Immunologic Efficacy of Antiretroviral Therapy among HIV-infected Patients in North America and Africa Elvin Geng* 1, Eric Vittinghoff 1, Jean Nachega.
BUSISIWE NKALA AFRI-CAN FORUM 17 – 19 JANUARY 2013 ENTEBBE, UGANDA FACTORS ASSOCIATED WITH BEING WILLING TO HAVE AN HIV TEST AMONG ADOLESCENTS IN SOWETO,
OVERVIEW OF THE HIV/AIDS EPIDEMIC Marie Laga
International Epidemiologic Databases to Evaluate AIDS Abstract-MOAB0202 XVIII International AIDS Conference, July 2010, Vienna, Austria 18-month mortality.
Retention of HIV+ pregnant and breastfeeding women on universal antiretroviral therapy (Option B+) in Malawi Lyson Tenthani* & Andreas Haas*, Hannock Tweya,
Good Three-year Outcomes of Antiretroviral Therapy at Multiple NGO- assisted facilities in Four Provinces in South Africa Geoffrey Fatti, Ashraf Grimwood.
The effect of tuberculosis treatment on virologic and immunologic response to combination antiretroviral therapy among South African children Heidi M.
ECONOMIC SPILLOVER EFFECTS OF HIV TREATMENT ON RURAL SOUTH AFRICAN HOUSEHOLDS Jacob Bor 1,2, Frank Tanser 1, Marie-Louise Newell 1,3, Till Bärnighausen.
Outcomes of Antiretroviral Treatment Programs in Rural Lesotho: Health Centers and Hospitals Compared Niklaus Labhardt, Motlalepula Sello, Mamokone A.
Mövenpick Royal Palm Hotel Dar es Salaam, Tanzania August 4-6, 2009 The 7th Annual Track 1.0 ART Program Meeting.
Outcomes in ART treatment programmes with and without access to routine viral load monitoring Olivia Keiser on behalf of IeDEA Southern Africa
Community-Based Adherence Support Associated with Improved Virological Suppression in Adults Receiving ART: Five-Year Outcomes from a South African Multicentre.
INS Point-Of-Care CD4 Improves Patient Retention and Time-To-Initiation for ART in Mozambique Ilesh Jani 1, Nádia Sitoe 1, Eunice Alfai 1, Patrina Chongo.
1 Scaling-up ARV Therapy in Vietnam HAIVN Harvard Medical School AIDS Initiative in Vietnam.
ICAP Quarterly Master Slide Set July-September 2007.
Successfully enrolled in HIV Care but not linked to timely Treatment: Poor retention and Monitoring of Pre-ART patients who are not yet eligible for ART.
Retention in an antiretroviral program in the Democratic Republic of Congo Kalenga Lucien Koole Olivier Menten Joris Kiumbu Modeste Robin Ryder Mukumbi.
Boston University Slideshow Title Goes Here District Prevalence of Unsuppressed HIV in South African Women: Monitoring Programme Performance and Progress.
Boston University Slideshow Title Goes Here Eliminating CD4 thresholds in South Africa will not lead to large increases in persons receiving ART without.
Priscilla Tsondai, Lynne Wilkinson, Anna Grimsrud, Angelina Trivino,
The clinical impact and cost-effectiveness of incorporating point-of-care (POC) assays into early infant HIV diagnosis (EID) programs at 6 weeks of age.
Contents - HIV global slides
Earlier treatment and lower mortality in infants Initiating ART at
Gaps in the cascade of care in two high prevalence settings in Zimbabwe and Malawi Nolwenn Conan1, Cyrus Paye2, Erica Simons2, Abraham Mapfumo3, Tsitsi.
Acceptability of early HIV treatment among South Africa women N Garrett, E Norman, V Asari, N Naicker, N Majola, K Leask, Q Abdool Karim and SS Abdool.
Is retention on ART underestimated due to patient transfers
BIPAI Network Experience with multi-month prescribing/refills (MMP)
MeSH: Optimizing the use of routine HIV data
ART Adherence Clubs South Africa
Tolerability of Isoniazid Preventive Therapy (IPT) in an HIV infected cohort
Getting to the second 90 in adolescent HIV: What is needed
First roll out of universal access to antiretroviral therapy under routine program conditions in rural Swaziland. Authors: Bernhard Kerschberger (1), Sikhathele.
Using HIV cohort collaboration data to evaluate and inform policy and practice Mary-Ann Davies.
Utilizing research as an opportunity to strengthen
A COLLABORATIVE APPROACH TO ESTABLISH PREDICTORS
ART Adherence Clubs South Africa
WHO HIV update July 2018 Global epidemic Global progress and cascade
The global epidemiology of perinatally HIV-infected adolescents:
Contents - HIV global slides
Dorina Onoya1, Tembeka Sineke1, Alana Brennan1,2, Matt Fox1,2
Jepkoech Kottutt1, Emilia D. Rivadeneira2, Susan Hrapcak2
Knowing your epidemic and knowing your response – maximising routinely collected data to measure and monitor HIV epidemics in sub-Saharan Africa Monitoring.
Cohort study of HIV+ children in Southern Africa returning to care after being lost to follow up: Effect of interrupting care on mortality 26th July 2018.
Extended ART Initiation Criteria Can Be Implemented Successfully in Rural South Africa Sarah Jane Steele1, Gemma Arellano2, Tom Ellman3, Amir Shroufi1,
Effect of POC CD4 testing at HIV diagnosis on attrition prior to ART initiation among youth in Khayelitsha, South Africa Pre-treatment losses to care remains.
24 July 2018 Treatment outcomes with bedaquiline use when substituted for second-line injectables in multidrug resistant tuberculosis: a retrospective.
Contents - HIV global slides
Economic Incentives for HIV testing in children and adolescents: Efforts to reach the first 95! Getting to the first 95 for children and adolescents:
Pediatric HIV Case Finding Strategies
Contents - HIV global slides
Systematic review: Perinatally HIV-infected infants in South Africa, total HIV-infected children aged 0–14 and the approaching wave of HIV-infected adolescents.
Andreas D. Haas, PhD Postdoctoral fellow, ICAP at Columbia University
HIV Recency Testing in Rwanda
Screening for mental and substance use disorders among adolescents on ART in Southern Africa
Apples and Oranges: Assessment of the Care Cascade in sub-Saharan Africa - Systematic Review of Criteria and Definitions used in Academic Papers Catrina.
Presentation transcript:

What does transfer mean in SSA What does transfer mean in SSA? Patterns of transfer in Southern African perinatally HIV-infected adolescents Mary-Ann Davies, Shobna Sawry, Sam Phiri, Helena Rabie, Brian Eley, Geoff Fatti, Karl Technau, Frank Tanser, Robin Wood, Janet Giddy, Carolyn Bolton-Moore, Cleophas Chimbetete, Rohan Hazra, Olivia Keiser and Kathryn Stinson for the IeDEA Southern Africa Collaboration 19 July, Durban

The wave of perinatally HIV-infected adolescents (PHA)

Growing population of PHA On ART Eligible, not on Rx Not eligible Johnson et al. PIDJ 2012

Changing age-structure of PHA in IeDEA-SA Age at last FU in those starting ART at <10 years 2008 N=15,144; 14%>10 years old 2014 N=28,520; 22%>10 years old

Outcomes of PHA by 13 years of age competing risks estimation Transfer out 18.2% (17.0-19.5) LTFU 9.3% (8.4-10.3) Death 1.2% (0.9-1.6)

Is transfer the same as transition? Specialist pediatric → adult care Completely integrated care Irrespective of model – transition is STILL happening Children stop coming with caregivers HCW talk to them about different things eg SRH needs Stop measuring height Use different form Illustrated by the cartoon – where it’s heading in HIV care – autonomy Transition ≈ Transfer ?Transfer

Objective To describe transfer patterns in PHA during first 3 years of adolescence – ages 10-13 years.

Methods Routinely collected data from 12 IeDEA-SA cohorts in 4 countries Inclusion criteria ART initiation at <9.5 years Remaining in care beyond 10 years of age Outcome = Transfer out (TFO) Characteristics of patients transferring K-M probability of transfer by cohort Predictors of transfer out Malawi Zambia Zimbabwe South Africa

Results: Characteristics at ART start for those remaining in care (RIC) or TFO n=3657 (excludes children died and LTFU within 6 months)

Results: Characteristics at transfer (TFO) or last visit (remaining in care)

Probability of transfer for different cohorts 25.6% (24.0 to 27.4) 14.0% (12.1-16.2) (pre-2009); 34.4% (31.8 – 37.1)(≥2009) Primary care cohorts Probability of transfer 6.5 (3.1-13.4) 5.1 (2.4-10.8) 10.1 (6.5-15.4) 14.8 (11.8-18.3) 17.3 (9.9-29.3) Hospital cohorts 36.3 (26.6-48.1) 7.6 (5.5-10.4) 45.3 (42.0-49.9) 45.0 (38.8-51.7) 54.3 (40.4-69.5) Months from 10 years of age

Characteristics associated with transfer

Limitations Documented transfers – not “silent transfers” Outcomes in patients who transfer out?

Outcomes after transfer using linkage Patients transferring out of a hospital site. Western Cape Province of South Africa – unique identifiers since 2007 – link to laboratory data. “Successful transfer” – having a laboratory test at the transfer site after transfer. 75% had a lab test result after transfer Lab testing only about 90% complete >80% of children successfully transferred Arowosegbe et al. P_66 HIV Pediatrics Workshop 2016

Conclusions About 1 in 4 patients transfer during early adolescence at a relatively constant rate, but wide variation between cohorts. “Healthier” patients were more likely to be transferred. on ART for longer, ↑CD4 values, ↓HIV-RNA Understanding patterns of transfer and outcomes after transfer is critical to evaluating adolescent and adolescent transition outcomes.

With many thanks to… Patients, caregivers, staff and site investigators from all IeDEA-SA sites IeDEA Data Centres NIAID, NICHD, NCI, NIDA, NIMH